Tachmed appoints assay development expert to support pioneering digital health product design

businessinthenews

Innovative medtech and life sciences business, Tachmed, has made an exciting new appointment to support the development of its pioneering digital health product.

 

Gita Parekh has joined the team as senior product manager for assay development, and with a PhD in Biomedical Sciences from Cardiff University, has a huge amount of knowledge and experience in the diagnostic industry.

Having spent the last 15 years working at leading developer and manufacturer of advanced lateral flow rapid diagnostic technologies, Global Access Diagnostics, Gita joins Tachmed from her role as Head of Respiratory.

 

Underpinned by its mission to make healthcare accessible to all, Tachmed is focused on enabling people to diagnose a multitude of medical conditions from the comfort of their own home using just one digital device.

 

Discussing her new role, Gita said: “I’m grateful to be joining the team at Tachmed at such an exciting time and am looking forward to supporting the development of its pioneering diagnostic product. Digital tools have huge potential to improve healthcare and opportunities for diagnosis, and at-home solutions cut down long waiting times that may delay patients’ results.

“The prospects for at-home diagnostics are exciting and will have a real impact on patients’ lives and the healthcare sector as a whole. I’m excited to get started.”

 

Paul Christie, founder and CEO of Tachmed, said: “Gita’s knowledge and experience is going to be a real asset to our team as we work to develop our digital diagnostics product, TachShield. Her expertise in assay development is second to none and will be key as we work through the process of designing and optimising.

“Improving the patient experience is central to our work, and our product is designed to do just that with the potential to reduce waiting list, speed up diagnosis, and even save lives. We’re working hard on development and are looking forward to our launch early next year.”

 

Tachmed has recently been recognised for its advances in diagnostic platform technology by the prestigious SEHTA Healthcare Business Awards, where it was shortlisted under the ‘Partnership between Academia & Business’ category for its successful collaboration with City St George’s University of London around assay development.

Headquartered in London, Tachmed was co-founded by Paul Christie, CEO, and Lord Maxwell Beaverbrook in 2018.

 

For more information, visit:

https://tachmed.com/